HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detailed clinical characterisation, unique features and natural history of autosomal recessive RDH12-associated retinal degeneration.

AbstractBACKGROUND:
Defects in retinol dehydrogenase 12 (RDH12) account for 3.4%-10.5 % of Leber congenital amaurosis and early-onset severe retinal dystrophy (EOSRD) and are a potential target for gene therapy. Clinical trials in inherited retinal diseases have unique challenges, and natural history studies are critical to successful trial design. The purpose of this study was to characterise the natural history of RDH12-associated retinal degeneration.
METHODS:
A retrospective chart review was performed in individuals with retinal degeneration and two likely disease-causing variants in RDH12.
RESULTS:
57 subjects were enrolled from nine countries. 33 subjects had clinical records available from childhood. The data revealed an EOSRD, with average age of onset of 4.1 years. Macular atrophy was a universal clinical finding in all subjects, as young as 2 years of age. Scotopic and photopic electroretinography (ERG) responses were markedly reduced in all subjects, and a non-recordable ERG was documented as young as 1 year of age. Assessment of visual acuity, visual field and optical coherence tomography revealed severe loss of function and structure in the majority of subjects after the age of 10 years. Widefield imaging in 23 subjects revealed a unique, variegated watercolour-like pattern of atrophy in 13 subjects and sparing of the peripapillary area in 18 subjects.
CONCLUSIONS:
This study includes the largest collection of phenotypic data from children with RDH12-associated EOSRD and provides a comprehensive description of the timeline of vision loss in this severe, early-onset condition. These findings will help identify patients with RDH12-associated retinal degeneration and will inform future design of therapeutic trials.
AuthorsAbigail T Fahim, Zaina Bouzia, Kari H Branham, Neruban Kumaran, Mauricio E Vargas, Kecia L Feathers, N Dayanthi Perera, Kelly Young, Naheed W Khan, John R Heckenlively, Andrew R Webster, Mark E Pennesi, Robin R Ali, Debra A Thompson, Michel Michaelides
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 103 Issue 12 Pg. 1789-1796 (12 2019) ISSN: 1468-2079 [Electronic] England
PMID30979730 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Chemical References
  • Alcohol Oxidoreductases
  • RDH12 protein, human
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Alcohol Oxidoreductases (genetics)
  • Child
  • Child, Preschool
  • Color Vision (physiology)
  • DNA Mutational Analysis
  • Electroretinography
  • Eye Diseases, Hereditary (diagnosis, genetics, physiopathology)
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Night Vision (physiology)
  • Phenotype
  • Retina (physiopathology)
  • Retinal Dystrophies (diagnosis, genetics, physiopathology)
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Visual Acuity (physiology)
  • Visual Fields (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: